Accession Number: | 0001415889-23-003077 |
Date: | 2023-02-17 |
Issuer: | ABBOTT LABORATORIES (ABT) |
Original Submission Date: |
WOODGRIFT RANDEL WILLIAM
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON SHARES WITHOUT PAR VALUE | 2023-02-17 | A | 9,504 | a | $0.00 | 57,358 | direct | ||
COMMON SHARES WITHOUT PAR VALUE | 2023-02-17 | 0 | $0.00 | 3,495 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION (RIGHT TO BUY) | 106.24 | 2023-02-17 | deemed execution date | A | 37,483 (a) | 2024-02-17 | 2033-02-16 | common shares 37,483 | $106.24 | 37,483 | direct |
ID | footnote |
---|---|
f1 | these shares represent a performance-based restricted stock award under the abbott laboratories 2017 incentive stock program. the award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon abbott reaching a minimum return on equity target. the award includes the right to have shares withheld for tax purposes. |
f2 | balance in the abbott laboratories stock retirement trust as of february 17, 2023. |
f3 | employee stock option granted pursuant to the abbott laboratories 2017 incentive stock program in a transaction exempt from section 16 under rule 16b-3. the option becomes exercisable in annual increments of 12,494 on february 17, 2024, 12,494 on february 17, 2025, and 12,495 on february 17, 2026. |